Pharma Reviews: Need to maintain Indian Pharma's export competitiveness with RoDTEP

It must be noted that the Indian pharmaceutical companies were one of the principal beneficiaries under MEIS, as they exported close to $20 billion ...
Read more: Need to maintain Indian Pharma's export competitiveness with RoDTEP